Debra A Schaumberg1, Reza Dana, Julie E Buring, David A Sullivan. 1. Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215, USA. dschaumberg@rics.bwh.harvard.edu
Abstract
OBJECTIVE: To estimate the prevalence and risk factors for dry eye disease (DED) among US men. METHODS: Cross-sectional prevalence survey among male participants 50 years and older in the Physicians' Health Studies I (N = 18,596) and II (N = 6848). We defined DED as the presence of clinically diagnosed dry eye or severe symptoms (both dryness and irritation constantly or often). We calculated the age-standardized prevalence of DED adjusted to the age distribution of US men in 2004 and projected estimates forward to 2030. We compared DED prevalence with a similar cohort of women and examined associations with possible risk factors. RESULTS: The prevalence of DED increased with age, from 3.90% among men aged 50 to 54 years to 7.67% among men 80 years and older (P for trend <.001). High blood pressure (odds ratio, 1.28; 95% confidence interval, 1.12-1.45) and benign prostatic hyperplasia (odds ratio, 1.26; 95% confidence interval, 1.09-1.44) were associated with a higher risk of DED. Use of antidepressants, antihypertensives, and medications to treat benign prostatic hyperplasia were also associated with increased risk of DED. The age-standardized prevalence of DED was 4.34%, or 1.68 million men 50 years and older, and is expected to affect more than 2.79 million US men by 2030. CONCLUSIONS: Dry eye disease is prevalent and increases with age, hypertension, benign prostatic hyperplasia, and antidepressant use.
RCT Entities:
OBJECTIVE: To estimate the prevalence and risk factors for dry eye disease (DED) among US men. METHODS: Cross-sectional prevalence survey among male participants 50 years and older in the Physicians' Health Studies I (N = 18,596) and II (N = 6848). We defined DED as the presence of clinically diagnosed dry eye or severe symptoms (both dryness and irritation constantly or often). We calculated the age-standardized prevalence of DED adjusted to the age distribution of US men in 2004 and projected estimates forward to 2030. We compared DED prevalence with a similar cohort of women and examined associations with possible risk factors. RESULTS: The prevalence of DED increased with age, from 3.90% among men aged 50 to 54 years to 7.67% among men 80 years and older (P for trend <.001). High blood pressure (odds ratio, 1.28; 95% confidence interval, 1.12-1.45) and benign prostatic hyperplasia (odds ratio, 1.26; 95% confidence interval, 1.09-1.44) were associated with a higher risk of DED. Use of antidepressants, antihypertensives, and medications to treat benign prostatic hyperplasia were also associated with increased risk of DED. The age-standardized prevalence of DED was 4.34%, or 1.68 million men 50 years and older, and is expected to affect more than 2.79 million US men by 2030. CONCLUSIONS:Dry eye disease is prevalent and increases with age, hypertension, benign prostatic hyperplasia, and antidepressant use.
Authors: D A Sullivan; H Yamagami; M Liu; R J Steagall; F Schirra; T Suzuki; K L Krenzer; J M Cermak; R M Sullivan; S M Richards; D A Schaumberg; M R Dana; B D Sullivan Journal: Adv Exp Med Biol Date: 2002 Impact factor: 2.622
Authors: Benjamin D Sullivan; James E Evans; Jennifer M Cermak; Kathleen L Krenzer; M Reza Dana; David A Sullivan Journal: Arch Ophthalmol Date: 2002-12
Authors: Michael E Stern; Karyn F Siemasko; Jianping Gao; Margarita Calonge; Jerry Y Niederkorn; Stephen C Pflugfelder Journal: Ocul Surf Date: 2005-10 Impact factor: 5.033
Authors: Biljana Miljanović; Komal A Trivedi; M Reza Dana; Jeffery P Gilbard; Julie E Buring; Debra A Schaumberg Journal: Am J Clin Nutr Date: 2005-10 Impact factor: 7.045
Authors: Bernardo Yáñez-Soto; Brian C Leonard; Vijay Krishna Raghunathan; Nicholas L Abbott; Christopher J Murphy Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799
Authors: Min Joung Lee; Ah Young Ko; Jung Hwa Ko; Hyun Ju Lee; Mee Kum Kim; Won Ryang Wee; Sang In Khwarg; Joo Youn Oh Journal: Mol Ther Date: 2014-08-25 Impact factor: 11.454
Authors: Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols Journal: Invest Ophthalmol Vis Sci Date: 2011-03-30 Impact factor: 4.799
Authors: Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana Journal: Ocul Surf Date: 2020-07-30 Impact factor: 5.033
Authors: Jeffrey P Lienert; Laura Tarko; Miki Uchino; William G Christen; Debra A Schaumberg Journal: Ophthalmology Date: 2015-11-21 Impact factor: 12.079